| Name | BCAT-IN-4 |
|---|
| Description | BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.35 μM (hBCATc)[1]. |
| References |
| Molecular Formula | C19H14N2O4S |
|---|---|
| Molecular Weight | 366.39 |